| Year |
Citation |
Score |
| 2021 |
Jakob D, Klesen A, Darkow E, Kari FA, Beyersdorf F, Kohl P, Ravens U, Peyronnet R. Heterogeneity and Remodeling of Ion Currents in Cultured Right Atrial Fibroblasts From Patients With Sinus Rhythm or Atrial Fibrillation. Frontiers in Physiology. 12: 673891. PMID 34149453 DOI: 10.3389/fphys.2021.673891 |
0.356 |
|
| 2021 |
Darkow E, Nguyen TT, Stolina M, Kari FA, Schmidt C, Wiedmann F, Baczkó I, Kohl P, Rajamani S, Ravens U, Peyronnet R. Small Conductance Ca-Activated K (SK) Channel mRNA Expression in Human Atrial and Ventricular Tissue: Comparison Between Donor, Atrial Fibrillation and Heart Failure Tissue. Frontiers in Physiology. 12: 650964. PMID 33868017 DOI: 10.3389/fphys.2021.650964 |
0.307 |
|
| 2020 |
Heijman J, Muna AP, Veleva T, Molina CE, Sutanto H, Tekook MA, Wang Q, Abu-Taha I, Gorka M, Künzel S, El-Armouche A, Reichenspurner H, Kamler M, Nikolaev VO, Ravens U, et al. Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Post-Operative Atrial Fibrillation. Circulation Research. PMID 32762493 DOI: 10.1161/Circresaha.120.316710 |
0.391 |
|
| 2020 |
Darkow E, Rog-Zielinska EA, Madl J, Brandel A, Siukstaite L, Omidvar R, Kohl P, Ravens U, Römer W, Peyronnet R. The Lectin LecA Sensitizes the Human Stretch-Activated Channel TREK-1 but Not Piezo1 and Binds Selectively to Cardiac Non-myocytes. Frontiers in Physiology. 11: 457. PMID 32499717 DOI: 10.3389/Fphys.2020.00457 |
0.384 |
|
| 2020 |
Künzel SR, Rausch JSE, Schäffer C, Hoffmann M, Künzel K, Klapproth E, Kant T, Herzog N, Küpper JH, Lorenz K, Dudek S, Emig R, Ravens U, Rog-Zielinska EA, Peyronnet R, et al. Modeling atrial fibrosis in vitro - Generation and characterization of a novel human atrial fibroblast cell line. Febs Open Bio. PMID 32421922 DOI: 10.1002/2211-5463.12896 |
0.411 |
|
| 2020 |
Kuenzel S, Klapproth E, Kuenzel K, Piorkowski C, Mayr M, Wagner M, Dobrev D, Rausch J, Ravens U, Weber S, El-Armouche A. PLK2 is a novel regulator of osteopontin-driven fibrosis and diastolic dysfunction in permanent atrial fibrillation European Heart Journal. 41. DOI: 10.1093/ehjci/ehaa946.3671 |
0.3 |
|
| 2019 |
Emig R, Zgierski-Johnston CM, Beyersdorf F, Rylski B, Ravens U, Weber W, Kohl P, Hörner M, Peyronnet R. Human Atrial Fibroblast Adaptation to Heterogeneities in Substrate Stiffness. Frontiers in Physiology. 10: 1526. PMID 31998137 DOI: 10.3389/Fphys.2019.01526 |
0.335 |
|
| 2019 |
Peyronnet R, Ravens U. Atria-selective antiarrhythmic drugs in need of alliance partners. Pharmacological Research. 145: 104262. PMID 31059791 DOI: 10.1016/J.Phrs.2019.104262 |
0.369 |
|
| 2019 |
Horsthemke M, Nutter LMJ, Bachg AC, Skryabin BV, Honnert U, Zobel T, Bogdan S, Stoll M, Seidl MD, Mueller FU, Ravens U, Unger A, Linke WA, van Gorp PRR, de Vries AAF, et al. A novel isoform of myosin 18A (Myo18Aγ) is an essential sarcomeric protein in mouse heart. The Journal of Biological Chemistry. PMID 30737279 DOI: 10.1074/Jbc.Ra118.004560 |
0.336 |
|
| 2019 |
Belau F, Metzner K, Christ T, Ravens U, Schaefer M, Künzel S, Li W, Wettwer E, Dobrev D, El-Armouche A, Kämmerer S. DPP10 is a new regulator of Nav1.5 channels in human heart. International Journal of Cardiology. PMID 30638748 DOI: 10.1016/J.Ijcard.2018.12.072 |
0.358 |
|
| 2018 |
Lemme M, Ulmer BM, Lemoine MD, Zech ATL, Flenner F, Ravens U, Reichenspurner H, Rol-Garcia M, Smith G, Hansen A, Christ T, Eschenhagen T. Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium. Stem Cell Reports. 11: 1378-1390. PMID 30416051 DOI: 10.1016/J.Stemcr.2018.10.008 |
0.371 |
|
| 2018 |
Molina CE, Abu-Taha IH, Wang Q, Roselló-Díez E, Kamler M, Nattel S, Ravens U, Wehrens XHT, Hove-Madsen L, Heijman J, Dobrev D. Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation. Frontiers in Physiology. 9: 1383. PMID 30356673 DOI: 10.3389/Fphys.2018.01383 |
0.43 |
|
| 2018 |
Ravens U. Sex differences in cardiac electrophysiology. Canadian Journal of Physiology and Pharmacology. 96: 985-990. PMID 30001496 DOI: 10.1139/Cjpp-2018-0179 |
0.335 |
|
| 2018 |
Rommel C, Rösner S, Lother A, Barg M, Schwaderer M, Gilsbach R, Bömicke T, Schnick T, Mayer S, Doll S, Hesse M, Kretz O, Stiller B, Neumann FJ, Mann M, ... ... Ravens U, et al. The Transcription Factor ETV1 Induces Atrial Remodeling and Arrhythmia. Circulation Research. PMID 29930145 DOI: 10.1161/Circresaha.118.313036 |
0.409 |
|
| 2018 |
Ravens U. Ionic basis of cardiac electrophysiology in zebrafish compared to human hearts. Progress in Biophysics and Molecular Biology. 138: 38-44. PMID 29913181 DOI: 10.1016/J.Pbiomolbio.2018.06.008 |
0.333 |
|
| 2018 |
Flenner F, Arlt N, Nasib M, Schobesberger S, Koch T, Ravens U, Friedrich F, Nikolaev V, Christ T, Stehr SN. In Vitro Negative Inotropic Effect of Low Concentrations of Bupivacaine Relates to Diminished Ca2+ Sensitivity but not to Ca2+ Handling or β-Adrenoceptor Signaling. Anesthesiology. PMID 29547406 DOI: 10.1097/Aln.0000000000002180 |
0.316 |
|
| 2018 |
Schneider-Warme F, Ravens U. Using light to fight atrial fibrillation. Cardiovascular Research. 114: 635-637. PMID 29452339 DOI: 10.1093/Cvr/Cvy041 |
0.312 |
|
| 2018 |
El-Battrawy I, Zhao Z, Lan H, Schünemann JD, Sattler K, Buljubasic F, Patocskai B, Li X, Yücel G, Lang S, Nowak D, Cyganek L, Bieback K, Utikal J, Zimmermann WH, ... Ravens U, et al. Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes. International Journal of Cardiology. 254: 195-202. PMID 29407091 DOI: 10.1016/J.Ijcard.2017.11.007 |
0.323 |
|
| 2018 |
Klesen A, Jakob D, Emig R, Kohl P, Ravens U, Peyronnet R. Cardiac fibroblasts : Active players in (atrial) electrophysiology? Herzschrittmachertherapie & Elektrophysiologie. 29: 62-69. PMID 29392412 DOI: 10.1007/S00399-018-0553-3 |
0.424 |
|
| 2018 |
Ravens U, Goette A. Advances in cardiac cellular electrophysiology - Relevance for clinical translation. Herzschrittmachertherapie & Elektrophysiologie. 29: 1-3. PMID 29372320 DOI: 10.1007/S00399-018-0556-0 |
0.321 |
|
| 2018 |
Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, ... ... Ravens U, et al. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 29300976 DOI: 10.1093/Europace/Eux318 |
0.363 |
|
| 2017 |
Heijman J, Kirchner D, Kunze F, Chrétien EM, Michel-Reher MB, Voigt N, Knaut M, Michel MC, Ravens U, Dobrev D. Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation. International Journal of Cardiology. PMID 29290419 DOI: 10.1016/J.Ijcard.2017.12.050 |
0.33 |
|
| 2017 |
Ravens U. Atrial-selective K channel blockers: potential antiarrhythmic drugs in atrial fibrillation? Canadian Journal of Physiology and Pharmacology. 95: 1313-1318. PMID 28738160 DOI: 10.1139/Cjpp-2017-0024 |
0.388 |
|
| 2017 |
Ravens U, Aalkjaer C. Cardiac heterogeneity and drug-provoked arrhythmias. Acta Physiologica. 221: 157-159. PMID 28613434 DOI: 10.1111/Apha.12907 |
0.328 |
|
| 2017 |
Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, ... ... Ravens U, et al. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. European Heart Journal. PMID 28057773 DOI: 10.1093/Eurheartj/Ehw559 |
0.42 |
|
| 2017 |
Ravens U, Odening KE. Atrial fibrillation: Therapeutic potential of atrial K channel blockers. Pharmacology & Therapeutics. 176: 13-21. PMID 27742566 DOI: 10.1016/J.Pharmthera.2016.10.003 |
0.408 |
|
| 2016 |
Liberos A, Bueno-Orovio A, Rodrigo M, Ravens U, Hernandez-Romero I, Fernandez-Aviles F, Guillem MS, Rodriguez B, Climent AM. Balance between sodium and calcium currents underlying chronic atrial fibrillation termination: An in silico inter-subject variability study. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 27569443 DOI: 10.1016/J.Hrthm.2016.08.028 |
0.381 |
|
| 2016 |
Peschke K, Achleitner M, Frenzel K, Gerbaulet A, Ada SR, Zeller N, Lienenklaus S, Lesche M, Poulet C, Naumann R, Dahl A, Ravens U, Günther C, Müller W, Knobeloch KP, et al. Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 27511730 DOI: 10.4049/Jimmunol.1600722 |
0.676 |
|
| 2016 |
Christ T, Kovács PP, Acsai K, Knaut M, Eschenhagen T, Iost N, Varró A, Wettwer E, Ravens U. Block of Na(+)/Ca(2+) exchanger by SEA0400 in human right atrial preparations from patients in sinus rhythm and in atrial fibrillation. European Journal of Pharmacology. PMID 27373849 DOI: 10.1016/J.Ejphar.2016.06.050 |
0.442 |
|
| 2016 |
Skibsbye L, Ravens U. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers. Cardiac Electrophysiology Clinics. 8: 395-410. PMID 27261830 DOI: 10.1016/J.Ccep.2016.02.004 |
0.367 |
|
| 2016 |
Berk E, Christ T, Schwarz S, Ravens U, Knaut M, Kaumann AJ. In permanent atrial fibrillation, PDE3 reduces force responses to 5-HT, but PDE3 and PDE4 do not cause the blunting of atrial arrhythmias. British Journal of Pharmacology. 173: 2478-89. PMID 27238373 DOI: 10.1111/Bph.13525 |
0.31 |
|
| 2016 |
Edelmann JC, Jones L, Peyronnet R, Lu L, Kohl P, Ravens U. A Bioreactor to Apply Multimodal Physical Stimuli to Cultured Cells. Methods in Molecular Biology (Clifton, N.J.). PMID 27032949 DOI: 10.1007/7651_2016_336 |
0.346 |
|
| 2016 |
Poulet C, Künzel S, Büttner E, Lindner D, Westermann D, Ravens U. Altered physiological functions and ion currents in atrial fibroblasts from patients with chronic atrial fibrillation. Physiological Reports. 4. PMID 26811054 DOI: 10.14814/Phy2.12681 |
0.754 |
|
| 2015 |
Ferrari R, Bertini M, Blomstrom-Lundqvist C, Dobrev D, Kirchhof P, Pappone C, Ravens U, Tamargo J, Tavazzi L, Vicedomini GG. An update on atrial fibrillation in 2014: From pathophysiology to treatment. International Journal of Cardiology. 203: 22-29. PMID 26490502 DOI: 10.1016/J.Ijcard.2015.10.089 |
0.397 |
|
| 2015 |
Kirchhof P, Breithardt G, Bax J, Benninger G, Blomstrom-Lundqvist C, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Calvert M, Christoffels V, Crijns H, Dobrev D, Ellinor P, ... ... Ravens U, et al. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 26481149 DOI: 10.1093/Europace/Euv304 |
0.361 |
|
| 2015 |
Schmid E, Neef S, Berlin C, Tomasovic A, Kahlert K, Nordbeck P, Deiss K, Denzinger S, Herrmann S, Wettwer E, Weidendorfer M, Becker D, Schäfer F, Wagner N, Ergün S, ... ... Ravens U, et al. Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy. Nature Medicine. PMID 26479924 DOI: 10.1038/Nm.3972 |
0.349 |
|
| 2015 |
Ford J, Milnes J, El Haou S, Wettwer E, Loose S, Matschke K, Tyl B, Round P, Ravens U. The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 26455450 DOI: 10.1016/J.Hrthm.2015.10.003 |
0.358 |
|
| 2015 |
Schotten U, Hatem S, Ravens U, Jaïs P, Müller FU, Goette A, Rohr S, Antoons G, Pieske B, Scherr D, Oto A, Casadei B, Verheule S, Cartlidge D, Steinmeyer K, et al. The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 17: 1457-66. PMID 26364316 DOI: 10.1093/Europace/Euv252 |
0.362 |
|
| 2015 |
Poulet C, Wettwer E, Grunnet M, Jespersen T, Fabritz L, Matschke K, Knaut M, Ravens U. Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation. Plos One. 10: e0131432. PMID 26121051 DOI: 10.1371/Journal.Pone.0131432 |
0.751 |
|
| 2015 |
Ravens U. Pathophysiology and progression of atrial fibrillation: Do we have a comprehensive model? Trends in Cardiovascular Medicine. 25: 485-6. PMID 25681991 DOI: 10.1016/J.Tcm.2015.01.003 |
0.368 |
|
| 2015 |
Turnow K, Metzner K, Cotella D, Morales MJ, Schaefer M, Christ T, Ravens U, Wettwer E, Kämmerer S. Interaction of DPP10a with Kv4.3 channel complex results in a sustained current component of human transient outward current Ito. Basic Research in Cardiology. 110: 5. PMID 25600224 DOI: 10.1007/S00395-014-0457-2 |
0.399 |
|
| 2015 |
Ravens U, Katircioglu-Öztürk D, Wettwer E, Christ T, Dobrev D, Voigt N, Poulet C, Loose S, Simon J, Stein A, Matschke K, Knaut M, Oto E, Oto A, Güvenir HA. Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillation. Medical & Biological Engineering & Computing. 53: 263-73. PMID 25466224 DOI: 10.1007/S11517-014-1232-0 |
0.696 |
|
| 2015 |
Reinecke H, Nabauer M, Gerth A, Limbourg T, Treszl A, Engelbertz C, Eckardt L, Kirchhof P, Wegscheider K, Ravens U, Meinertz T, Steinbeck G, Breithardt G. Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease. Kidney International. 87: 200-9. PMID 24897032 DOI: 10.1038/Ki.2014.195 |
0.321 |
|
| 2015 |
Poulet C, Rajamani S, Ravens U, Belardinelli L. Effects of Ik,Ach Channel Inhibitor Tertiapin-Q on Right Atrial Preparations from Patients in Sinus Rhythm and Atrial Fibrillation Biophysical Journal. 108. DOI: 10.1016/J.Bpj.2014.11.1520 |
0.724 |
|
| 2015 |
Ravens U, Katircioglu-Öztürk D, Wettwer E, Poulet C, Loose S, Knaut M, Oto E, Oto A, Güvenir HA. Application of the RIMARC Algorithm to a Large Data Set of Action Potentials and Clinical Parameters for Risk Prediction of Atrial Fibrillation Biophysical Journal. 108: 2-4. DOI: 10.1016/J.Bpj.2014.11.1505 |
0.714 |
|
| 2014 |
Greiser M, Kerfant BG, Williams GS, Voigt N, Harks E, Dibb KM, Giese A, Meszaros J, Verheule S, Ravens U, Allessie MA, Gammie JS, van der Velden J, Lederer WJ, Dobrev D, et al. Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. The Journal of Clinical Investigation. 124: 4759-72. PMID 25329692 DOI: 10.1172/Jci70102 |
0.32 |
|
| 2014 |
Sánchez C, Bueno-Orovio A, Wettwer E, Loose S, Simon J, Ravens U, Pueyo E, Rodriguez B. Inter-subject variability in human atrial action potential in sinus rhythm versus chronic atrial fibrillation. Plos One. 9: e105897. PMID 25157495 DOI: 10.1371/Journal.Pone.0105897 |
0.365 |
|
| 2014 |
Christ T, Rozmaritsa N, Engel A, Berk E, Knaut M, Metzner K, Canteras M, Ravens U, Kaumann A. Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proceedings of the National Academy of Sciences of the United States of America. 111: 11193-8. PMID 25024212 DOI: 10.1073/Pnas.1324132111 |
0.412 |
|
| 2014 |
Quinn TA, Kohl P, Ravens U. Cardiac mechano-electric coupling research: fifty years of progress and scientific innovation. Progress in Biophysics and Molecular Biology. 115: 71-5. PMID 24978820 DOI: 10.1016/J.Pbiomolbio.2014.06.007 |
0.379 |
|
| 2014 |
Skibsbye L, Poulet C, Diness JG, Bentzen BH, Yuan L, Kappert U, Matschke K, Wettwer E, Ravens U, Grunnet M, Christ T, Jespersen T. Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria. Cardiovascular Research. 103: 156-67. PMID 24817686 DOI: 10.1093/Cvr/Cvu121 |
0.715 |
|
| 2014 |
Davies L, Jin J, Shen W, Tsui H, Shi Y, Wang Y, Zhang Y, Hao G, Wu J, Chen S, Fraser JA, Dong N, Christoffels V, Ravens U, Huang CL, et al. Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age. Journal of the American Heart Association. 3: e000340. PMID 24721794 DOI: 10.1161/Jaha.113.000340 |
0.344 |
|
| 2014 |
Loose S, Mueller J, Wettwer E, Knaut M, Ford J, Milnes J, Ravens U. Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation. Frontiers in Pharmacology. 5: 26. PMID 24624083 DOI: 10.3389/Fphar.2014.00026 |
0.441 |
|
| 2014 |
Ravens U. [New developments in the antiarrhythmic therapy of atrial fibrillation]. Herzschrittmachertherapie & Elektrophysiologie. 25: 41-6. PMID 24496483 DOI: 10.1007/S00399-014-0302-1 |
0.391 |
|
| 2014 |
Rozmaritsa N, Christ T, Van Wagoner DR, Haase H, Stasch JP, Matschke K, Ravens U. Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation. Cardiovascular Research. 101: 533-42. PMID 24336332 DOI: 10.1093/Cvr/Cvt334 |
0.374 |
|
| 2014 |
Poulet C, Fabritz L, Ravens U. P377Late sodium current as a promising drug target for treatment of atrial fibrillation Cardiovascular Research. 103. DOI: 10.1093/Cvr/Cvu091.60 |
0.746 |
|
| 2013 |
Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A, Bailleul C, Bax J, Benninger G, Blomstrom-Lundqvist C, Boersma L, Boriani G, Brandes A, Brown H, Brueckmann M, ... ... Ravens U, et al. Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 15: 1540-56. PMID 23981824 DOI: 10.1093/Europace/Eut232 |
0.366 |
|
| 2013 |
Szuts V, Ménesi D, Varga-Orvos Z, Zvara Ã, Houshmand N, Bitay M, Bogáts G, Virág L, Baczkó I, Szalontai B, Geramipoor A, Cotella D, Wettwer E, Ravens U, Deák F, et al. Altered expression of genes for Kir ion channels in dilated cardiomyopathy. Canadian Journal of Physiology and Pharmacology. 91: 648-56. PMID 23889090 DOI: 10.1139/Cjpp-2012-0413 |
0.344 |
|
| 2013 |
Jost N, Virág L, Comtois P, Ordög B, Szuts V, Seprényi G, Bitay M, Kohajda Z, Koncz I, Nagy N, Szél T, Magyar J, Kovács M, Puskás LG, Lengyel C, ... ... Ravens U, et al. Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs. The Journal of Physiology. 591: 4189-206. PMID 23878377 DOI: 10.1113/Jphysiol.2013.261198 |
0.37 |
|
| 2013 |
Ravens U, Poulet C, Wettwer E, Knaut M. Atrial selectivity of antiarrhythmic drugs. The Journal of Physiology. 591: 4087-97. PMID 23732646 DOI: 10.1113/Jphysiol.2013.256115 |
0.747 |
|
| 2013 |
Voigt N, Heijman J, Trausch A, Mintert-Jancke E, Pott L, Ravens U, Dobrev D. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation. Journal of Molecular and Cellular Cardiology. 61: 142-52. PMID 23531443 DOI: 10.1016/J.Yjmcc.2013.03.011 |
0.39 |
|
| 2013 |
Molenaar P, Christ T, Hussain RI, Engel A, Berk E, Gillette KT, Chen L, Galindo-Tovar A, Krobert KA, Ravens U, Levy FO, Kaumann AJ. PDE3, but not PDE4, reduces β₠- and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. British Journal of Pharmacology. 169: 528-38. PMID 23489141 DOI: 10.1111/Bph.12167 |
0.328 |
|
| 2013 |
Ford J, Milnes J, Wettwer E, Christ T, Rogers M, Sutton K, Madge D, Virag L, Jost N, Horvath Z, Matschke K, Varro A, Ravens U. Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor. Journal of Cardiovascular Pharmacology. 61: 408-15. PMID 23364608 DOI: 10.1097/Fjc.0B013E31828780Eb |
0.37 |
|
| 2013 |
Wettwer E, Christ T, Endig S, Rozmaritsa N, Matschke K, Lynch JJ, Pourrier M, Gibson JK, Fedida D, Knaut M, Ravens U. The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovascular Research. 98: 145-54. PMID 23341576 DOI: 10.1093/Cvr/Cvt006 |
0.44 |
|
| 2013 |
Radicke S, Riedel T, Cotella D, Turnow K, Ravens U, Schaefer M, Wettwer E. Accessory subunits alter the temperature sensitivity of Kv4.3 channel complexes Journal of Molecular and Cellular Cardiology. 56: 8-18. PMID 23291429 DOI: 10.1016/J.Yjmcc.2012.12.017 |
0.305 |
|
| 2013 |
Lu L, Mende M, Yang X, Körber HF, Schnittler HJ, Weinert S, Heubach J, Werner C, Ravens U. Design and validation of a bioreactor for simulating the cardiac niche: a system incorporating cyclic stretch, electrical stimulation, and constant perfusion. Tissue Engineering. Part A. 19: 403-14. PMID 22991978 DOI: 10.1089/Ten.Tea.2012.0135 |
0.343 |
|
| 2012 |
Protze S, Khattak S, Poulet C, Lindemann D, Tanaka EM, Ravens U. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. Journal of Molecular and Cellular Cardiology. 53: 323-32. PMID 22575762 DOI: 10.1016/J.Yjmcc.2012.04.010 |
0.703 |
|
| 2012 |
Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S, Wehrens XHT, Dobrev D. Enhanced sarcoplasmic reticulum Ca 2+ Leak and increased Na +-Ca 2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation Circulation. 125: 2059-2070. PMID 22456474 DOI: 10.1161/Circulationaha.111.067306 |
0.331 |
|
| 2012 |
Löhle M, Hermann A, Glass H, Kempe A, Schwarz SC, Kim JB, Poulet C, Ravens U, Schwarz J, Schöler HR, Storch A. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells (Dayton, Ohio). 30: 570-9. PMID 22213586 DOI: 10.1002/Stem.1016 |
0.668 |
|
| 2012 |
Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, ... ... Ravens U, et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 14: 8-27. PMID 21791573 DOI: 10.1093/Europace/Eur241 |
0.359 |
|
| 2012 |
Goette A, Hammwöhner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, Dobrev D, Ravens U, Weinert S, Medunjanin S, Lendeckel U, Bode-Böger SM. The impact of rapid atrial pacing on ADMA and endothelial NOS International Journal of Cardiology. 154: 141-146. PMID 20926145 DOI: 10.1016/J.Ijcard.2010.09.004 |
0.357 |
|
| 2012 |
Hatem S, Schotten U, Rohr S, Dobrev D, Ravens U, Goette A, Pieske B, Kockskämper J, Lendeckel U, Casadei B, Kirchhof P, Müller FU, Jais P, Oto A, Camm AJ. The European Network for Translational Research in Atrial Fibrillation Clinical Investigation. 2: 1061-1067. DOI: 10.4155/Cli.12.103 |
0.332 |
|
| 2012 |
Leone A, Aquila I, Vicinanza C, Iaconetti C, Bochicchio A, Ottolenghi S, Indolfi C, Nadal-Ginard B, Ellison GM, Torella D, Mias C, Genet G, Guilbeau-Frugier C, Pathak A, Senard JM, ... ... Ravens U, et al. Oral abstract presentations & Young Investigators Competition Cardiovascular Research. 93: S46-S51. DOI: 10.1093/Cvr/Cvr333 |
0.468 |
|
| 2012 |
Schmidt M, Bussek A, Himmel H, Ravens U, Wettwer E, Lohmann H. Pharmacological studies in acute rabbit cardiac slices Journal of Pharmacological and Toxicological Methods. 66: 182. DOI: 10.1016/J.Vascn.2012.08.084 |
0.333 |
|
| 2011 |
Quinn TA, Granite S, Allessie MA, Antzelevitch C, Bollensdorff C, Bub G, Burton RA, Cerbai E, Chen PS, Delmar M, Difrancesco D, Earm YE, Efimov IR, Egger M, Entcheva E, ... ... Ravens U, et al. Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing. Progress in Biophysics and Molecular Biology. 107: 4-10. PMID 21745496 DOI: 10.1016/J.Pbiomolbio.2011.07.001 |
0.312 |
|
| 2011 |
Szél T, Koncz I, Jost N, Baczkó I, Husti Z, Virág L, Bussek A, Wettwer E, Ravens U, Papp JG, Varró A. Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations. European Journal of Pharmacology. 662: 31-9. PMID 21550338 DOI: 10.1016/J.Ejphar.2011.04.042 |
0.362 |
|
| 2011 |
Ravens U, Wettwer E. Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovascular Research. 89: 776-85. PMID 21159668 DOI: 10.1093/Cvr/Cvq398 |
0.4 |
|
| 2011 |
Poulet C, Wettwer E, Christ T, Ravens U. Skeletal muscle stem cells propagated as myospheres display electrophysiological properties modulated by culture conditions. Journal of Molecular and Cellular Cardiology. 50: 357-66. PMID 20971120 DOI: 10.1016/J.Yjmcc.2010.10.011 |
0.738 |
|
| 2011 |
Wiese C, Nikolova T, Zahanich I, Sulzbacher S, Fuchs J, Yamanaka S, Graf E, Ravens U, Boheler KR, Wobus AM. Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin. International Journal of Cardiology. 147: 95-111. PMID 19775764 DOI: 10.1016/J.Ijcard.2009.08.021 |
0.308 |
|
| 2011 |
Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, ... Ravens U, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. European Heart Journal. 30: 2969-77c. PMID 19535417 DOI: 10.1093/Eurheartj/Ehp235 |
0.348 |
|
| 2011 |
Rozmaritsa N, Christ T, Wettwer E, Ravens U. NO-donors induce cross talk between cGMP and cAMP in signalling to human atrial L-type Ca2+ current Bmc Pharmacology. 11: 55. DOI: 10.1186/1471-2210-11-S1-P55 |
0.3 |
|
| 2011 |
Schmidt M, Bauriedl J, Bussek A, Wettwer E, Ravens U, Lohmann H. Field potential screening of action potential propagation in rodent cardiac slices Journal of Pharmacological and Toxicological Methods. 64. DOI: 10.1016/J.Vascn.2011.03.040 |
0.304 |
|
| 2011 |
Bussek A, Lohmann H, Schmidt M, Wettwer E, Ravens U. Cardiac slices as a new alternative model in safety pharmacology Journal of Pharmacological and Toxicological Methods. 64. DOI: 10.1016/J.Vascn.2011.03.038 |
0.304 |
|
| 2010 |
Ravens U, Christ T. Atrial-selective drugs for treatment of atrial fibrillation Herzschrittmachertherapie Und Elektrophysiologie. 21: 217-221. PMID 21082185 DOI: 10.1007/S00399-010-0088-8 |
0.366 |
|
| 2010 |
Nabauer M, Gerth A, Kirchhof P, Goette A, Limbourg T, Sprenger C, Hoffmann B, Willems S, Doll N, Schuchert A, Oeff M, Ravens U, Meinertz T, Steinbeck G, Breithardt G. [Registry and studies of the German Competence Network on Atrial Fibrillation (AFNET)]. Herzschrittmachertherapie & Elektrophysiologie. 21: 153-9. PMID 20676664 DOI: 10.1007/S00399-010-0097-7 |
0.36 |
|
| 2010 |
Wakili R, Yeh Y, Qi XY, Greiser M, Chartier D, Nishida K, Maguy A, Villeneuve L, Boknik P, Voigt N, Krysiak J, Kääb S, Ravens U, Linke WA, Stienen GJM, et al. Multiple Potential Molecular Contributors to Atrial Hypocontractility Caused by Atrial Tachycardia Remodeling in Dogs Circulation-Arrhythmia and Electrophysiology. 3: 530-541. PMID 20660541 DOI: 10.1161/Circep.109.933036 |
0.379 |
|
| 2010 |
Voigt N, Trausch A, Knaut M, Matschke K, Varró A, Van Wagoner DR, Nattel S, Ravens U, Dobrev D. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circulation. Arrhythmia and Electrophysiology. 3: 472-80. PMID 20657029 DOI: 10.1161/Circep.110.954636 |
0.36 |
|
| 2010 |
Ravens U. Antiarrhythmic therapy in atrial fibrillation. Pharmacology & Therapeutics. 128: 129-145. PMID 20624425 DOI: 10.1016/J.Pharmthera.2010.06.004 |
0.416 |
|
| 2010 |
Cotella D, Radicke S, Bortoluzzi A, Ravens U, Wettwer E, Santoro C, Sblattero D. Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of Ito channel complex. Pflugers Archiv : European Journal of Physiology. 460: 87-97. PMID 20354865 DOI: 10.1007/S00424-010-0824-2 |
0.375 |
|
| 2010 |
Ravens U. Atrial fibrillation and circulating endothelial progenitor cells. Europace. 12: 460-461. PMID 20139437 DOI: 10.1093/Europace/Euq010 |
0.362 |
|
| 2010 |
Ravens U. Novel pharmacological approaches for antiarrhythmic therapy. Naunyn-Schmiedebergs Archives of Pharmacology. 381: 187-193. PMID 20082192 DOI: 10.1007/S00210-009-0487-8 |
0.415 |
|
| 2010 |
Voigt N, Rozmaritsa N, Trausch A, Zimniak T, Christ T, Wettwer E, Matschke K, Dobrev D, Ravens U. Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation Naunyn-Schmiedebergs Archives of Pharmacology. 381: 251-259. PMID 19760273 DOI: 10.1007/S00210-009-0452-6 |
0.383 |
|
| 2010 |
Nemtsas P, Wettwer E, Christ T, Weidinger G, Ravens U. Adult zebrafish heart as a model for human heart? An electrophysiological study. Journal of Molecular and Cellular Cardiology. 48: 161-171. PMID 19747484 DOI: 10.1016/J.Yjmcc.2009.08.034 |
0.389 |
|
| 2010 |
Dimova I, Hlushchuk R, Makanya A, Djonov V, Theurl M, Schgoer W, Albrecht K, Beer A, Patsch JR, Schratzberger P, Mahata S, Kirchmair R, Didie M, Christalla P, Rau T, ... ... Ravens U, ... ... Ravens U, ... ... Ravens U, ... ... Ravens U, ... ... Ravens U, ... ... Ravens U, et al. Saturday, 17 July 2010 Cardiovascular Research. 87: S45-S88. DOI: 10.1093/cvr/cvq174 |
0.622 |
|
| 2009 |
Bussek A, Wettwer E, Christ T, Lohmann H, Camelliti P, Ravens U. Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cellular Physiology and Biochemistry. 24: 527-536. PMID 19910693 DOI: 10.1159/000257528 |
0.373 |
|
| 2009 |
Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schunck W, Ehrhart-Bornstein M, Bornstein SR, Morano I. Adipocyte Fatty Acid–Binding Protein Suppresses Cardiomyocyte Contraction: A New Link Between Obesity and Heart Disease Circulation Research. 105: 326-334. PMID 19608978 DOI: 10.1161/Circresaha.109.200501 |
0.338 |
|
| 2009 |
Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, ... Ravens U, et al. Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 11: 860-85. PMID 19531542 DOI: 10.1093/Europace/Eup124 |
0.358 |
|
| 2009 |
Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Röhl FW, Wolke C, Bergmann S, Bramlage P, Ravens U, Lendeckel U. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. European Heart Journal. 30: 1411-20. PMID 19269986 DOI: 10.1093/Eurheartj/Ehp046 |
0.316 |
|
| 2009 |
Radicke S, Cotella D, Sblattero D, Ravens U, Santoro C, Wettwer E. The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 617-26. PMID 19153714 DOI: 10.1007/S00210-008-0389-1 |
0.322 |
|
| 2009 |
Christ T, Galindo-Tovar A, Thoms M, Ravens U, Kaumann AJ. Inotropy and L‐type Ca2+ current, activated by β1‐ and β2‐adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart British Journal of Pharmacology. 156: 62-83. PMID 19133992 DOI: 10.1111/J.1476-5381.2008.00015.X |
0.321 |
|
| 2009 |
Greiser M, Neuberger HR, Harks E, El-Armouche A, Boknik P, de Haan S, Verheyen F, Verheule S, Schmitz W, Ravens U, Nattel S, Allessie MA, Dobrev D, Schotten U. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. Journal of Molecular and Cellular Cardiology. 46: 385-94. PMID 19100271 DOI: 10.1016/J.Yjmcc.2008.11.012 |
0.427 |
|
| 2009 |
Christ T, Wettwer E, Voigt N, Hála O, Radicke S, Matschke K, Várro A, Dobrev D, Ravens U. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation British Journal of Pharmacology. 154: 1619-1630. PMID 18536759 DOI: 10.1038/Bjp.2008.209 |
0.445 |
|
| 2009 |
Radicke S, Vaquero M, Caballero R, Gómez R, Núñez L, Tamargo J, Ravens U, Wettwer E, Delpón E. Effects of MiRP1 and DPP6 β‐subunits on the blockade induced by flecainide of KV4.3/KChIP2 channels British Journal of Pharmacology. 154: 774-786. PMID 18536731 DOI: 10.1038/Bjp.2008.134 |
0.336 |
|
| 2009 |
Voigt N, Trausch A, Matschke K, Ravens U, Dobrev D. Presence of Left-to-Right Atrial Inward Rectifier Potassium Current Gradient in Patients with Paroxysmal but Not Chronic Atrial Fibrillation Heart Rhythm. 6: 1691-1692. DOI: 10.1016/J.Hrthm.2009.09.049 |
0.373 |
|
| 2008 |
Yeh YH, Wakili R, Qi XY, Chartier D, Boknik P, Kääb S, Ravens U, Coutu P, Dobrev D, Nattel S. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circulation. Arrhythmia and Electrophysiology. 1: 93-102. PMID 19808399 DOI: 10.1161/Circep.107.754788 |
0.367 |
|
| 2008 |
Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 11: 423-434. PMID 19153087 DOI: 10.1093/Europace/Eun369 |
0.318 |
|
| 2008 |
Breithardt G, Dobrev D, Doll N, Goette A, Hoffmann B, Kirchhof P, Köster I, Kuck KH, Leute A, Meinertz T, Näbauer M, Oeff M, Ravens U, Schuchert A, Sprenger C, et al. The German Competence Network on Atrial Fibrillation (AFNET). Herz. 33: 548-55. PMID 19137244 DOI: 10.1007/S00059-008-3177-2 |
0.367 |
|
| 2008 |
Wuest M, Christ T, Hiller N, Braeter M, Ravens U. Effects of three metabolites of propiverine on voltage-dependent L-type calcium currents in human atrial myocytes. European Journal of Pharmacology. 598: 94-97. PMID 18796302 DOI: 10.1016/J.Ejphar.2008.08.035 |
0.331 |
|
| 2008 |
Ravens U, Cerbai E. Role of potassium currents in cardiac arrhythmias. Europace. 10: 1133-1137. PMID 18653669 DOI: 10.1093/Europace/Eun193 |
0.381 |
|
| 2008 |
Ravens U. Potassium channels in atrial fibrillation: targets for atrial and pathology-specific therapy? Heart Rhythm. 5: 758-759. PMID 18452882 DOI: 10.1016/J.Hrthm.2007.11.008 |
0.425 |
|
| 2008 |
Christ T, Wettwer E, Wuest M, Braeter M, Donath F, Champeroux P, Richard S, Ravens U. Electrophysiological profile of propiverine--relationship to cardiac risk. Naunyn-Schmiedebergs Archives of Pharmacology. 376: 431-440. PMID 18092154 DOI: 10.1007/S00210-007-0231-1 |
0.429 |
|
| 2008 |
Poulet C, Proksch S, Ravens U. Cardiomyogenic potential of skeletal muscle-derived progenitor cells Journal of Molecular and Cellular Cardiology. 44: 744-745. DOI: 10.1016/J.Yjmcc.2008.02.081 |
0.681 |
|
| 2007 |
Voigt N, Maguy A, Yeh Y, Qi X, Ravens U, Dobrev D, Nattel S. Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovascular Research. 77: 35-43. PMID 18006448 DOI: 10.1093/Cvr/Cvm051 |
0.417 |
|
| 2007 |
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener H, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck K, Lip GYH, Olsson B, Meinertz T, Priori S, ... Ravens U, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace. 9: 1006-1023. PMID 17897925 DOI: 10.1093/Europace/Eum191 |
0.31 |
|
| 2007 |
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener H, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck K, Lip GYH, Olsson B, Meinertz T, Priori S, ... Ravens U, et al. Outcome parameters for trials in atrial fibrillation: executive summary. European Heart Journal. 28: 2803-2817. PMID 17897924 DOI: 10.1093/Eurheartj/Ehm358 |
0.301 |
|
| 2007 |
Stehr SN, Christ T, Rasche B, Rasche S, Wettwer E, Deussen A, Ravens U, Koch T, Hübler M. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations. Anesthesia and Analgesia. 105: 641-7. PMID 17717217 DOI: 10.1213/01.Ane.0000278146.15671.03 |
0.301 |
|
| 2007 |
Greiser M, Halaszovich CR, Frechen D, Boknik P, Ravens U, Dobrev D, Lückhoff A, Schotten U. Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn-Schmiedebergs Archives of Pharmacology. 375: 383-392. PMID 17593353 DOI: 10.1007/S00210-007-0174-6 |
0.352 |
|
| 2007 |
Wuest M, Hiller N, Braeter M, Hakenberg OW, Wirth MP, Ravens U. Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouse. European Journal of Pharmacology. 565: 180-189. PMID 17395173 DOI: 10.1016/J.Ejphar.2007.02.046 |
0.314 |
|
| 2007 |
Voigt N, Friedrich A, Bock M, Wettwer E, Christ T, Knaut M, Strasser RH, Ravens U, Dobrev D. Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovascular Research. 74: 426-437. PMID 17362895 DOI: 10.1016/J.Cardiores.2007.02.009 |
0.3 |
|
| 2007 |
Ravens U. Regulation of cardiac sodium channels by tyrosine kinases - contribution to excitability? Journal of Molecular and Cellular Cardiology. 42: 733-734. PMID 17320101 DOI: 10.1016/J.Yjmcc.2007.01.011 |
0.332 |
|
| 2007 |
Wettwer E, Christ T, Dobrev D, Ravens U. Novel anti-arrhythmic agents for the treatment of atrial fibrillation Current Opinion in Pharmacology. 7: 214-218. PMID 17303472 DOI: 10.1016/J.Coph.2006.10.007 |
0.38 |
|
| 2007 |
Dobrev D, Christ T, Boknik P, Wöhrl S, Bosch R-, Ravens U. Regulation of l-type Ca2+ channels in left atria of patients with chronic atrial fibrillation Journal of Molecular and Cellular Cardiology. 42. DOI: 10.1016/J.Yjmcc.2007.03.058 |
0.379 |
|
| 2007 |
Christ T, Wettwer E, Ravens U. The effect of flecainide on conduction is not diminished in human atrial fibrillation Journal of Molecular and Cellular Cardiology. 42. DOI: 10.1016/J.Yjmcc.2007.03.028 |
0.37 |
|
| 2006 |
Balana B, Nicoletti C, Zahanich I, Graf EM, Christ T, Boxberger S, Ravens U. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Research. 16: 949-60. PMID 17160070 DOI: 10.1038/Sj.Cr.7310116 |
0.381 |
|
| 2006 |
Christ T, Wettwer E, Ravens U. Letter by Christ et al Regarding Article, “Angiotensin II Potentiates the Slow Component of Delayed Rectifier K+ Current via the AT1 Receptor in Guinea Pig Atrial Myocytes” Circulation. 114. PMID 17075020 DOI: 10.1161/Circulationaha.106.639377 |
0.314 |
|
| 2006 |
Leute A, Kirchhof P, Breithardt G, Goette A, Lewalter T, Meinertz T, Oeff M, Ravens U, Steinbeck G, Weiss T. [German Competence Network on Atrial Fibrillation (AFNET). A nationwide cooperation for better research and patient care]. Medizinische Klinik (Munich, Germany : 1983). 101: 662-6. PMID 16896574 DOI: 10.1007/S00063-006-1096-7 |
0.328 |
|
| 2006 |
El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D. Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation Circulation. 114: 670-680. PMID 16894034 DOI: 10.1161/Circulationaha.106.636845 |
0.305 |
|
| 2006 |
Christ T, Schindelhauer S, Wettwer E, Wallukat G, Ravens U. Interaction between autoantibodies against the β1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes Journal of Molecular and Cellular Cardiology. 41: 716-723. PMID 16889792 DOI: 10.1016/J.Yjmcc.2006.06.011 |
0.306 |
|
| 2006 |
Radicke S, Cotella D, Graf EM, Banse U, Jost N, Varró A, Tseng GN, Ravens U, Wettwer E. Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Cardiovascular Research. 71: 695-703. PMID 16876774 DOI: 10.1016/J.Cardiores.2006.06.017 |
0.338 |
|
| 2006 |
Hansen RS, Diness TG, Christ T, Wettwer E, Ravens U, Olesen SP, Grunnet M. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea]. Molecular Pharmacology. 70: 1319-29. PMID 16825484 DOI: 10.1124/Mol.106.026492 |
0.362 |
|
| 2006 |
Ständker L, Béress L, Garateix A, Christ T, Ravens U, Salceda E, Soto E, John H, Forssmann WG, Aneiros A. A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Toxicon : Official Journal of the International Society On Toxinology. 48: 211-20. PMID 16814340 DOI: 10.1016/J.Toxicon.2006.05.001 |
0.333 |
|
| 2006 |
Ravens U, Dobrev D, Goette A. New aspects in the treatment of atrial fibrillation Herzschrittmachertherapie Und Elektrophysiologie. 17: 61-63. PMID 16786463 DOI: 10.1007/S00399-006-0511-3 |
0.322 |
|
| 2006 |
Dobrev D, Ravens U. Do genetics help to better understand the underlying mechanisms of atrial fibrillation? European Heart Journal. 27: 1640-1641. PMID 16760202 DOI: 10.1093/Eurheartj/Ehl076 |
0.406 |
|
| 2006 |
Molenaar P, Christ T, Ravens U, Kaumann A. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Cardiovascular Research. 69: 128-39. PMID 16225854 DOI: 10.1016/J.Cardiores.2005.08.024 |
0.303 |
|
| 2006 |
Hansen RS, Diness TG, Christ T, Demnitz J, Ravens U, Olesen SP, Grunnet M. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Molecular Pharmacology. 69: 266-77. PMID 16219910 DOI: 10.1124/Mol.105.015859 |
0.394 |
|
| 2006 |
Christ T, Wettwer E, Ravens U, Olesen S, Grunnet M. Activation of outward potassium current ikr by the diphenylurea ns 1643 shortens action potential in gunea pig papillary muscles Journal of Molecular and Cellular Cardiology. 40: 983-984. DOI: 10.1016/J.Yjmcc.2006.03.188 |
0.306 |
|
| 2006 |
El-Armouche A, Knaut M, Eschenhagen T, Ravens U, Dobrev D. Phospholamban and troponin I phosphorylation in remodeled left atria from patients with sinus rhythm and chronic atrial fibrillation Journal of Molecular and Cellular Cardiology. 40: 927. DOI: 10.1016/J.Yjmcc.2006.03.035 |
0.337 |
|
| 2005 |
Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U. The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation Circulation. 112: 3697-3706. PMID 16330682 DOI: 10.1161/Circulationaha.105.575332 |
0.407 |
|
| 2005 |
Wuest M, Kaden S, Hakenberg OW, Wirth MP, Ravens U. Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium. Naunyn-Schmiedebergs Archives of Pharmacology. 372: 203-212. PMID 16283254 DOI: 10.1007/S00210-005-0015-4 |
0.355 |
|
| 2005 |
Christ T, Ravens U. Do we need new antiarrhythmic compounds in the era of implantable cardiac devices and percutaneous ablation Cardiovascular Research. 68: 341-343. PMID 16256089 DOI: 10.1016/J.Cardiores.2005.09.013 |
0.368 |
|
| 2005 |
Zahanich I, Graf EM, Heubach JF, Hempel U, Boxberger S, Ravens U. Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 1637-46. PMID 16059635 DOI: 10.1359/Jbmr.050521 |
0.361 |
|
| 2005 |
Christ T, Wettwer E, Ravens U. Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of ICa,L Naunyn-Schmiedebergs Archives of Pharmacology. 371: 393-400. PMID 15959721 DOI: 10.1007/S00210-005-1063-5 |
0.358 |
|
| 2005 |
Ellinghaus P, Scheubel RJ, Dobrev D, Ravens U, Holtz J, Huetter J, Nielsch U, Morawietz H. Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. The Journal of Thoracic and Cardiovascular Surgery. 129: 1383-1390. PMID 15942582 DOI: 10.1016/J.Jtcvs.2004.08.031 |
0.37 |
|
| 2005 |
Graf EM, Bock M, Heubach JF, Zahanich I, Boxberger S, Richter W, Schultz JH, Ravens U. Tissue distribution of a human Ca v 1.2 alpha1 subunit splice variant with a 75 bp insertion. Cell Calcium. 38: 11-21. PMID 15916803 DOI: 10.1016/J.Ceca.2005.03.005 |
0.325 |
|
| 2005 |
Radicke S, Cotella D, Graf EM, Ravens U, Wettwer E. Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. The Journal of Physiology. 565: 751-6. PMID 15890703 DOI: 10.1113/Jphysiol.2005.087312 |
0.365 |
|
| 2005 |
Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 111: 2025-32. PMID 15851612 DOI: 10.1161/01.Cir.0000162461.67140.4C |
0.417 |
|
| 2005 |
Cotella D, Jost N, Darna M, Radicke S, Ravens U, Wettwer E. Silencing the cardiac potassium channel Kv4.3 by RNA interference in a CHO expression system. Biochemical and Biophysical Research Communications. 330: 555-60. PMID 15796918 DOI: 10.1016/J.Bbrc.2005.03.018 |
0.306 |
|
| 2005 |
Jean-Baptiste G, Li X, Yang Z, Heubach J, Gaudio S, Khoury C, Ravens U, Greenwood MT. Beta adrenergic receptor-mediated atrial specific up-regulation of RGS5. Life Sciences. 76: 1533-45. PMID 15680317 DOI: 10.1016/J.Lfs.2004.11.001 |
0.311 |
|
| 2005 |
Christ T, Adolph E, Schindelhauer S, Wettwer E, Dobrev D, Wallukat G, Ravens U. Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes. Basic & Clinical Pharmacology & Toxicology. 96: 445-452. DOI: 10.1111/J.1742-7843.2005.Pto_96607.X |
0.325 |
|
| 2005 |
Dobrev D, Voigt N, Christ T, Wettwer E, Knaut M, Ravens U. Dynamic regulation of IK,ACh by protein kinases in human atrial myocytes: Influence of chronic atrial fibrillation Heart Rhythm. 2. DOI: 10.1016/J.Hrthm.2005.02.054 |
0.312 |
|
| 2005 |
Dobrev D, Friedrich A, Knuschke D, Christ T, Wettwer E, Knaut M, Ravens U. The 825T-allele of the GNB3 gene is associated with higher basal inward rectifier current in human chronic atrial fibrillation Heart Rhythm. 2. DOI: 10.1016/J.Hrthm.2005.02.052 |
0.317 |
|
| 2004 |
Christ T, Rauwolf T, Braun M, Dobrev D, Ravens U, Strasser RH. Recording atrial monophasic action potentials using standard pacemaker leads: an alternative way to study electrophysiology properties of the human atrium in vivo? Pacing and Clinical Electrophysiology. 27: 1632-1637. PMID 15613126 DOI: 10.1111/J.1540-8159.2004.00696.X |
0.347 |
|
| 2004 |
Christ T, Wüst M, Matthes J, Jänchen M, Jürgens S, Herzig S, Wettwer E, Dobrev D, Matschke K, Mebs D, Ravens U. An aqueous extract of the marine sponge Ectyoplasia ferox stimulates L-type Ca2+-current by direct interaction with the Cav1.2 subunit. Naunyn-Schmiedeberg's Archives of Pharmacology. 370: 474-83. PMID 15599709 DOI: 10.1007/S00210-004-0996-4 |
0.366 |
|
| 2004 |
Christ T, Boknik P, Wöhrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D. L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation. 110: 2651-7. PMID 15492323 DOI: 10.1161/01.Cir.0000145659.80212.6A |
0.369 |
|
| 2004 |
Wettwer E, Hála O, Christ T, Heubach JF, Dobrev D, Knaut M, Varró A, Ravens U. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation. 110: 2299-2306. PMID 15477405 DOI: 10.1161/01.Cir.0000145155.60288.71 |
0.4 |
|
| 2004 |
Dobrev D, Christ T, Ravens U. Muscarinic subtype-2 receptor autoantibodies: Actors or bystanders in human atrial fibrillation? European Heart Journal. 25: 1091-1092. PMID 15231365 DOI: 10.1016/J.Ehj.2004.05.001 |
0.425 |
|
| 2004 |
Heubach JF, Ravens U, Kaumann AJ. Epinephrine Activates Both Gs and Gi Pathways, but Norepinephrine Activates Only the Gs Pathway through Human β2-Adrenoceptors Overexpressed in Mouse Heart Molecular Pharmacology. 65: 1313-1322. PMID 15102960 DOI: 10.1124/Mol.65.5.1313 |
0.325 |
|
| 2004 |
Heubach JF, Graf EM, Leutheuser J, Bock M, Balana B, Zahanich I, Christ T, Boxberger S, Wettwer E, Ravens U. Electrophysiological properties of human mesenchymal stem cells. The Journal of Physiology. 554: 659-72. PMID 14578475 DOI: 10.1113/Jphysiol.2003.055806 |
0.375 |
|
| 2003 |
Balana B, Dobrev D, Wettwer E, Christ T, Knaut M, Ravens U. Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. Journal of Molecular and Cellular Cardiology. 35: 1399-405. PMID 14654366 DOI: 10.1016/S0022-2828(03)00246-3 |
0.367 |
|
| 2003 |
Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation Basic Research in Cardiology. 98: 137-148. PMID 12883831 DOI: 10.1007/S00395-003-0409-8 |
0.382 |
|
| 2003 |
Ravens U. Mechano-electric feedback and arrhythmias. Progress in Biophysics & Molecular Biology. 82: 255-266. PMID 12732284 DOI: 10.1016/S0079-6107(03)00026-9 |
0.397 |
|
| 2003 |
Kohl P, Ravens U. Cardiac mechano-electric feedback: past, present, and prospect. Progress in Biophysics & Molecular Biology. 82: 3-9. PMID 12732264 DOI: 10.1016/S0079-6107(03)00022-1 |
0.36 |
|
| 2003 |
Ravens U, Dobrev D. Cardiac sympathetic innervation and control of potassium channel function Journal of Molecular and Cellular Cardiology. 35: 137-139. PMID 12606253 DOI: 10.1016/S0022-2828(02)00307-3 |
0.352 |
|
| 2003 |
Dobrev D, Ravens U. Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum European Journal of Pharmacology. 461: 105-111. PMID 12586205 DOI: 10.1016/S0014-2999(03)01319-0 |
0.32 |
|
| 2003 |
Graf EM, Dobrev D, Heubach JF, Bock M, Ravens U. 901 Post‐operative atrial fibrillation after coronary artery bypass grafting is predicted by enhanced mRNA levels of the L‐type Ca2+ channel alpha1C subunit European Journal of Heart Failure Supplements. 2: 187-187. DOI: 10.1016/S1567-4215(03)90565-0 |
0.301 |
|
| 2002 |
Wüst M, Averbeck B, Reif S, Bräter M, Ravens U. Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse European Journal of Pharmacology. 454: 59-69. PMID 12409006 DOI: 10.1016/S0014-2999(02)02478-0 |
0.307 |
|
| 2002 |
Li SN, Hu G, Bräter M, Andreas K, Ravens U. An interaction between ATP and high K+: mutual impairment of ATP- and high K(+)-evoked [Ca2+]i increase in NG 108-15 cells. Neurochemical Research. 27: 451-5. PMID 12199148 DOI: 10.1023/A:1019836316887 |
0.308 |
|
| 2002 |
Eschenhagen T, Didié M, Heubach J, Ravens U, Zimmermann W. Cardiac tissue engineering Transplant Immunology. 9: 315-321. PMID 12180846 DOI: 10.1016/S0966-3274(02)00011-4 |
0.361 |
|
| 2002 |
Dobrev D, Wettwer E, Kortner A, Knaut M, Schüler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovascular Research. 54: 397-404. PMID 12062344 DOI: 10.1016/S0008-6363(01)00555-7 |
0.334 |
|
| 2002 |
Christ T, Wettwer E, Müller D, Wallukat G, Ravens U. Anti-β1-adrenoceptor autoantibodies increase L-type Ca2+ current in human atrial myocytes Journal of Molecular and Cellular Cardiology. 34. DOI: 10.1016/S0022-2828(02)90793-5 |
0.34 |
|
| 2001 |
Dobrev D, Graf E, Wettwer E, Himmel HM, Hála O, Doerfel C, Christ T, Schüler S, Ravens U. Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials. Circulation. 104: 2551-7. PMID 11714649 DOI: 10.1161/Hc4601.099466 |
0.381 |
|
| 2001 |
Himmel HM, Stengel W, Ravens U. Selectivity of blocking of low- versus high-voltage activated calcium currents by the dihydropyridine derivatives Bay E5759 and Bay A4339 in neuroblastoma--glioma NG 108-15 cells. Pharmacological Research. 44: 113-116. PMID 11516260 DOI: 10.1006/Phrs.2001.0836 |
0.318 |
|
| 2001 |
Himmel HM, Wettwer E, Lues I, Beier N, Jonas R, Ravens U. Three thiadiazinone derivatives, EMD 60417, EMD 66430, and EMD 66398, with class III antiarrhythmic activity but different electrophysiologic profiles. Journal of Cardiovascular Pharmacology. 38: 438-449. PMID 11486248 DOI: 10.1097/00005344-200109000-00012 |
0.375 |
|
| 2001 |
Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U. Autoantibodies Against the β1adrenoceptor from Patients with Dilated Cardiomyopathy Prolong Action Potential Duration and Enhance Contractility in Isolated Cardiomyocytes Journal of Molecular and Cellular Cardiology. 33: 1515-1525. PMID 11448139 DOI: 10.1006/Jmcc.2001.1414 |
0.33 |
|
| 2001 |
Li S, Blaschke M, Heubach JF, Wettwer E, Ravens U. Effects of azelastine on contractility, action potentials and L-type Ca2+ current in guinea pig cardiac preparations European Journal of Pharmacology. 418: 7-14. PMID 11334859 DOI: 10.1016/S0014-2999(01)00923-2 |
0.369 |
|
| 2001 |
Grossmann M, Dobrev D, Himmel HM, Ravens U, Kirch W. Ascorbic Acid–Induced Modulation of Venous Tone in Humans Hypertension. 37: 949-954. PMID 11244023 DOI: 10.1161/01.Hyp.37.3.949 |
0.307 |
|
| 2000 |
Dobrev D, Wettwer E, Himmel HM, Kortner A, Kuhlisch E, Schüler S, Siffert W, Ravens U. G-Protein β3-Subunit 825T Allele Is Associated With Enhanced Human Atrial Inward Rectifier Potassium Currents Circulation. 102: 692-697. PMID 10931811 DOI: 10.1161/01.Cir.102.6.692 |
0.33 |
|
| 2000 |
Himmel HM, Meyer Zu Heringdorf D, Graf E, Dobrev D, Kortner A, Schüler S, Jakobs KH, Ravens U. Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. Molecular Pharmacology. 58: 449-54. PMID 10908314 DOI: 10.1124/Mol.58.2.449 |
0.316 |
|
| 2000 |
Heubach JF, Köhler A, Wettwer E, Ravens U. T-Type and Tetrodotoxin-Sensitive Ca2+ Currents Coexist in Guinea Pig Ventricular Myocytes and Are Both Blocked by Mibefradil Circulation Research. 86: 628-635. PMID 10746997 DOI: 10.1161/01.Res.86.6.628 |
0.303 |
|
| 2000 |
Ravens U, Dobrev D. Regulation of sarcoplasmic reticulum Ca2+-ATPase and phospholamban in the failing and nonfailing heart Cardiovascular Research. 45: 245-252. PMID 10728342 DOI: 10.1016/S0008-6363(99)00338-7 |
0.374 |
|
| 1999 |
Freestone NS, Heubach JF, Wettwer E, Ravens U, Brown D, Kaumann AJ. β4-Adrenoceptors are more effective than β1-adrenoceptors in mediating arrhythmic Ca2+ transients in mouse ventricular myocytes Naunyn-Schmiedebergs Archives of Pharmacology. 360: 445-456. PMID 10551282 DOI: 10.1007/S002109900075 |
0.304 |
|
| 1999 |
Himmel HM, Wettwer E, Li Q, Ravens U. Four different components contribute to outward current in rat ventricular myocytes. American Journal of Physiology-Heart and Circulatory Physiology. 277. PMID 10409188 DOI: 10.1152/Ajpheart.1999.277.1.H107 |
0.307 |
|
| 1999 |
Dobrev D, Milde AS, Andreas K, Ravens U. The effects of verapamil and diltiazem on N‐, P‐ and Q‐type calcium channels mediating dopamine release in rat striatum British Journal of Pharmacology. 127: 576-582. PMID 10385261 DOI: 10.1038/Sj.Bjp.0702574 |
0.316 |
|
| 1999 |
Bräter M, Li S, Gorodezkaya IJ, Andreas K, Ravens U. Voltage-sensitive Ca2+ channels, intracellular Ca2+ stores and Ca2+-release-activated Ca2+ channels contribute to the ATP-induced [Ca2+]i increase in differentiated neuroblastoma×glioma NG 108-15 cells Neuroscience Letters. 264: 97-100. PMID 10320023 DOI: 10.1016/S0304-3940(99)00189-5 |
0.303 |
|
| 1999 |
Ravens U, Himmel HM. Drugs preventing Na+ and Ca2+ overload. Pharmacological Research. 39: 167-174. PMID 10094840 DOI: 10.1006/Phrs.1998.0416 |
0.325 |
|
| 1999 |
Himmel HM, Amos GJ, Wettwer E, Ravens U. Effects of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264 on cardiac ionic currents of guinea pig and rat ventricular myocytes. Journal of Cardiovascular Pharmacology. 33: 301-308. PMID 10028941 DOI: 10.1097/00005344-199902000-00019 |
0.388 |
|
| 1998 |
Dobrev D, Milde AS, Andreas K, Ravens U. Voltage-activated calcium channels involved in veratridine-evoked [3H]dopamine release in rat striatal slices Neuropharmacology. 37: 973-982. PMID 9833626 DOI: 10.1016/S0028-3908(98)00103-8 |
0.317 |
|
| 1998 |
Ravens U, Wettwer E. Electrophysiological aspects of changes in heart rate Basic Research in Cardiology. 93: 99-108. PMID 9833132 DOI: 10.1007/S003950050220 |
0.37 |
|
| 1998 |
Wettwer E, Himmel HM, Amos GJ, Li Q, Metzger F, Ravens U. Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes British Journal of Pharmacology. 125: 659-666. PMID 9831899 DOI: 10.1038/Sj.Bjp.0702110 |
0.365 |
|
| 1998 |
Neumann T, Ravens U, Heusch G. Characterization of excitation–contraction coupling in conscious dogs with pacing-induced heart failure Cardiovascular Research. 37: 456-466. PMID 9614500 DOI: 10.1016/S0008-6363(97)00246-0 |
0.325 |
|
| 1998 |
Ravens U, Himmel HM. [+]‐EMD 60263—A Novel, Selective, Calcium‐Sensitizing Agent Cardiovascular Drug Reviews. 16: 346-358. DOI: 10.1111/J.1527-3466.1998.Tb00363.X |
0.35 |
|
| 1997 |
Ravens U, Gath J, Hussaini MA, Himmel H. Mechanical Restitution in Atrial Muscle from Human and Rat Hearts: Effects of Agents that Modify Sarcoplasmic Reticulum Function Pharmacology & Toxicology. 81: 97-104. PMID 9298507 DOI: 10.1111/J.1600-0773.1997.Tb00038.X |
0.364 |
|
| 1997 |
Ravens U, Flüß MO, Li Q, Himmel HM, Wettwer E, Klockow M, Lues I. Stereoselectivity of actions of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264. Naunyn-Schmiedebergs Archives of Pharmacology. 355: 733-742. PMID 9205958 DOI: 10.1007/Pl00005007 |
0.393 |
|
| 1996 |
Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U. Differences between outward currents of human atrial and subepicardial ventricular myocytes. The Journal of Physiology. 491: 31-50. PMID 9011620 DOI: 10.1113/Jphysiol.1996.Sp021194 |
0.454 |
|
| 1996 |
Li Q, Himmel HM, Ravens U. Selectivity of class-III antiarrhythmic action of clofilium in guinea pig ventricular myocytes. Journal of Cardiovascular Pharmacology. 27: 401-410. PMID 8907802 DOI: 10.1097/00005344-199603000-00013 |
0.379 |
|
| 1996 |
Ravens U, Mahl C, Ohler A, Hardman SMC, Noble MIM. Mechanical restitution and recirculation fraction in cardiac myocytes and left ventricular muscle of adult rats. Basic Research in Cardiology. 91: 123-130. PMID 8740528 DOI: 10.1007/Bf00799684 |
0.335 |
|
| 1996 |
Ravens U, Himmel HM, Flüss M, Davia K, Harding SE. Phosphodiesterase Inhibition And Ca2+ Sensitization Molecular and Cellular Biochemistry. 157: 245-249. PMID 8739254 DOI: 10.1007/Bf00227906 |
0.393 |
|
| 1996 |
Ravens U, Davia K, Davies CH, O'Gara P, Drake-Holland AJ, Hynd JW, Noble MIM, Harding SE. Tachycardia-induced failure alters contractile properties of canine ventricular myocytes Cardiovascular Research. 32: 613-621. DOI: 10.1016/S0008-6363(96)00121-6 |
0.357 |
|
| 1995 |
Ravens U, Link S, Gath J, Noble MI. Post-rest potentiation and its decay after inotropic interventions in isolated rat heart muscle. Pharmacology & Toxicology. 76: 9-16. PMID 7753767 DOI: 10.1111/J.1600-0773.1995.Tb00095.X |
0.368 |
|
| 1995 |
Ravens U, Amos GJ, Ehring T, Heusch G. BDF 9148—A Sodium Channel Modulator with Positive Inotropic Action Cardiovascular Drug Reviews. 13: 260-274. DOI: 10.1111/J.1527-3466.1995.Tb00307.X |
0.305 |
|
| 1994 |
Wettwer E, Amos GJ, Posival H, Ravens U. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circulation Research. 75: 473-482. PMID 8062421 DOI: 10.1161/01.Res.75.3.473 |
0.35 |
|
| 1994 |
Ohler A, Amos GJ, Wettwer E, Ravens U. Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block Naunyn-Schmiedebergs Archives of Pharmacology. 349: 602-610. PMID 7969512 DOI: 10.1007/Bf01258466 |
0.334 |
|
| 1994 |
Hoey A, Harrison SM, Boyett MR, Ravens U. Effects of the Anemonia sulcata toxin (ATX II) on intracellular sodium and contractility in rat and guinea-pig myocardium. Pharmacology & Toxicology. 75: 356-65. PMID 7899257 DOI: 10.1111/J.1600-0773.1994.Tb00375.X |
0.334 |
|
| 1994 |
Mewes T, Ravens U. L-type Calcium Currents of Human Myocytes from Ventricle of Non-failing and Failing Hearts and from Atrium Journal of Molecular and Cellular Cardiology. 26: 1307-1320. PMID 7869391 DOI: 10.1006/Jmcc.1994.1149 |
0.397 |
|
| 1994 |
Amos GJ, Ravens U. The inotropic agents DPI 201-106 and BDF 9148 differentially affect potassium currents of guinea-pig ventricular myocytes. Naunyn-Schmiedebergs Archives of Pharmacology. 350: 426-433. PMID 7845480 DOI: 10.1007/Bf00178962 |
0.355 |
|
| 1994 |
Hoey A, Amos GJ, Ravens U. Comparison of the action potential prolonging and positive inotropic activity of DPI 201-106 and BDF 9148 in human ventricular myocardium. Journal of Molecular and Cellular Cardiology. 26: 985-994. PMID 7799453 DOI: 10.1006/Jmcc.1994.1119 |
0.384 |
|
| 1994 |
Hoey A, Amos GJ, Wettwer E, Ravens U. Differential effects of BDF 9148 and DPI 201-106 on action potential and contractility in rat and guinea pig myocardium. Journal of Cardiovascular Pharmacology. 23: 907-915. PMID 7523782 DOI: 10.1097/00005344-199406000-00008 |
0.333 |
|
| 1994 |
Li Q, Himmel HM, Ravens U. Effects of the new phosphodiesterase-III inhibitor R80122 on contractility and calcium current in human cardiac tissue. Journal of Cardiovascular Pharmacology. 24: 133-143. PMID 7521478 DOI: 10.1097/00005344-199407000-00021 |
0.355 |
|
| 1993 |
Hoey A, Lehmkuhl A, Sadony V, Ravens U. Inotropic actions of BDF 9148 and DPI 201-106 and their enantiomers in guinea-pig, rat and human atria European Journal of Pharmacology. 231: 477-480. PMID 8449239 DOI: 10.1016/0014-2999(93)90128-5 |
0.326 |
|
| 1993 |
Wettwer E, Amos G, Gath J, Zerkowski H, Reidemeister J, Ravens U. Transient outward current in human and rat ventricular myocytes Cardiovascular Research. 27: 1662-1669. PMID 8287446 DOI: 10.1093/Cvr/27.9.1662 |
0.35 |
|
| 1993 |
Mewes T, Dutz S, Ravens U, Jakobs KH. Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors. Circulation. 88: 2916-2922. PMID 8252705 DOI: 10.1161/01.Cir.88.6.2916 |
0.343 |
|
| 1992 |
Ravens U, Guo-shu L, Vandeplassche G, Borgers M. Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+. Cardiovascular Drugs and Therapy. 6: 47-58. PMID 1576096 DOI: 10.1007/Bf00050917 |
0.332 |
|
| 1992 |
Wettwer E, Himmel H, Ravens U. Amiloride derivatives as blockers of Na+/Ca2+ exchange: effects on mechanical and electrical function of guinea-pig myocardium. Pharmacology & Toxicology. 71: 95-102. PMID 1438035 DOI: 10.1111/J.1600-0773.1992.Tb00526.X |
0.404 |
|
| 1992 |
Wettwer E, Grundke M, Ravens U. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes Cardiovascular Research. 26: 1145-1152. PMID 1291093 DOI: 10.1093/Cvr/26.11.1145 |
0.314 |
|
| 1992 |
Wettwer E, Flüß M, Gath J, Mewes T, Hoey A, Grundke M, Hauser G, Zerkowski H-, Reidemeister JC, Ravens U. The transient outward current in cardiac myocytes from patients with terminal heart failure and from rats Journal of Molecular and Cellular Cardiology. 24. DOI: 10.1016/0022-2828(92)91608-8 |
0.335 |
|
| 1992 |
Mewes T, Wettwer E, Gath J, Hoey A, Grundke M, Hauser G, Zerkowski H-, Reidemeister JC, Ravens U. Oral presentation II: 10.40–12.20l-type calcium current in cardiac myocytes from patients with terminal cardiac failure or ischemic heart disease and from guinea pigs Journal of Molecular and Cellular Cardiology. 24. DOI: 10.1016/0022-2828(92)91556-K |
0.359 |
|
| 1992 |
Ravens U, Hauser G, Wettwer E. Effects of alpha1-adrenoceptor stimulation on two components of transient outward current (Ito) in rat cardiac myocytes Journal of Molecular and Cellular Cardiology. 24: 145. DOI: 10.1016/0022-2828(92)90460-H |
0.307 |
|
| 1992 |
Hoey A, Wettwer E, Ravens U. Effects of BDF 9148 and DPI 201-106 on mechanical, bioelectrical and Na+ activity in human, rat and guinea-pig heart muscle Journal of Molecular and Cellular Cardiology. 24: 84. DOI: 10.1016/0022-2828(92)90277-7 |
0.321 |
|
| 1991 |
Guo-shu L, Ravens U, Sadony V, Vandeplassche G, Borgers M. Functional and structural impairment in human, rat and guinea-pig atrial muscle in response to in vitro calcium overload: a cytochemical study on cellular calcium distribution. Journal of Molecular and Cellular Cardiology. 23: 795-805. PMID 1791631 DOI: 10.1016/0022-2828(91)90213-6 |
0.309 |
|
| 1991 |
Himmel HM, Schappert T, Ravens U. Combined effects of volatile anesthetics and phosphodiesterase inhibitors on contractile performance in guinea pig hearts. Anesthesia & Analgesia. 73: 76-82. PMID 1713427 DOI: 10.1213/00000539-199107000-00014 |
0.316 |
|
| 1991 |
Wettwer E, Scholtysik G, Schaad A, Himmel H, Ravens U. Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. Journal of Cardiovascular Pharmacology. 17: 480-487. PMID 1711611 DOI: 10.1097/00005344-199103000-00018 |
0.336 |
|
| 1991 |
Ravens U, Wettwer E, Pfeifer T, Himmel H, Armah B. Characterization of the effects of the new inotropic agent BDF 9148 in isolated papillary muscles and myocytes of the guinea‐pig heart British Journal of Pharmacology. 104: 1019-1023. PMID 1667282 DOI: 10.1111/J.1476-5381.1991.Tb12543.X |
0.388 |
|
| 1991 |
Ravens U, Pfeifer T, Wettwer E, Grundke M. Inhibition of the myocardial Ca2+‐current (ICa) by the enantiomers of DPI 201–106 and BDF 8784 British Journal of Pharmacology. 104: 490-494. PMID 1665740 DOI: 10.1111/J.1476-5381.1991.Tb12456.X |
0.307 |
|
| 1990 |
Himmel HM, Wilhelm D, Ravens U. Effects of R56865 on membrane currents in isolated ventricular cardiomyocytes of the guinea-pig. European Journal of Pharmacology. 187: 235-240. PMID 1703080 DOI: 10.1016/0014-2999(90)90010-4 |
0.337 |
|
| 1990 |
Ravens U, Schöpper H. Opposite cardiac actions of the enantiomers of Bay K 8644 at different membrane potentials in guinea-pig papillary muscles Naunyn-Schmiedebergs Archives of Pharmacology. 341: 232-239. PMID 1692975 DOI: 10.1007/Bf00169736 |
0.301 |
|
| 1990 |
Ravens U, Himmel H, Wettwer E, Eggert K, Heber D. The positive inotropic action of some 4-aminoquinoline derivatives in isolated heart muscle of the guinea pig European Journal of Pharmacology. 183: 2106. DOI: 10.1016/0014-2999(90)93623-X |
0.306 |
|
| 1990 |
Himmel HM, Wettwer E, Wilhelm D, Ravens U. Modification of cardiac membrane currents by R56865: a whole-cell patch-clamp study European Journal of Pharmacology. 183: 275-276. DOI: 10.1016/0014-2999(90)93127-C |
0.315 |
|
| 1989 |
Armah BI, Pfeifer T, Ravens U. Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative. British Journal of Pharmacology. 96: 807-816. PMID 2568142 DOI: 10.1111/J.1476-5381.1989.Tb11888.X |
0.362 |
|
| 1989 |
Ravens U, Wettwer E. Modulation of sodium/calcium exchange: a hypothetical positive inotropic mechanism. Journal of Cardiovascular Pharmacology. 14. DOI: 10.1097/00005344-198914003-00007 |
0.332 |
|
| 1987 |
Cragoe E, Ravens U, Wettwer E. Amiloride derivatives that block Na+/Ca2+ exchange inhibit spontaneous inward currents in Na+-loaded cardiac myocytes European Journal of Pharmacology. 140: 113-116. PMID 2442010 DOI: 10.1016/0014-2999(87)90642-X |
0.342 |
|
| 1979 |
Gertjegerdes W, Ravens U, Ziegler A. Time courses of carbachol-induced responses in guinea pig atria under the influence of ouabain, calcium, and rate of stimulation. Journal of Cardiovascular Pharmacology. 1: 235-244. PMID 94392 DOI: 10.1097/00005344-197903000-00006 |
0.302 |
|
| Show low-probability matches. |